Preprint Microbiota-derived extracellular vesicles link intestinal dysbiosis to neuroimmune activation in long COVID, 2026, Aranguren et al.

[SNT Gatchaman]

Microbiota-derived extracellular vesicles link intestinal dysbiosis to neuroimmune activation in long COVID

Spoiler: Authors

Matheus Aranguren; Kim Doyon-Laliberte; Idia Boncheva; Alexandre Villard; Alehandra Desjardins; Emma Darbinian; Suhani Patel; Charlotte DuSablon; Estefania Rivera Conde; Diana Cabrera Munoz; Ludhovik Purchase; Valerio Ec Piscopo; Aeshah Alluli; Faiza Benaliouad; Julien Sirois; Thomas Durcan; Chantal Masse; Kodjovi Dodji Mlaga; Prabha Chandrasekaran; Johanne Poudrier; Emilia Liana Falcone

Post COVID-19 condition (Long COVID, LC) is frequently accompanied by persistent neurological symptoms, but the mechanisms linking intestinal dysbiosis to neuroinflammation remain unclear.

Here we identify gut microbiota-derived extracellular vesicles (GMEVs) as functional mediators linking LC-associated dysbiosis to systemic and neuroimmune inflammation. In a longitudinally characterized cohort, individuals with LC and neurological symptoms exhibit a persistent intestinal microbiome signature.

Transplantation of LC-associated microbiota into germ-free mice induces intestinal barrier disruption and neuroinflammatory phenotypes. GMEVs from individuals with LC activate inflammasome-associated programs and impair epithelial barrier function, promote inflammatory responses in macrophages, and induce coordinated pro-inflammatory transcriptional programs in human induced pluripotent stem cell (iPSC)-derived microglia. Chronic oral administration of LC-derived GMEVs remodels the microbiota and induces intestinal and systemic inflammation with glial activation in vivo.

Together, these findings support a vesicle-centered framework in which microbiota-derived extracellular vesicles translate dysbiosis into sustained immune and neuroimmune activation in a post-viral inflammatory state.

Web | DOI | PDF | Preprint: BioRxiv | Open Access

 

[V.R.T.]

I have some gut issues (diagnosed with SIBO last year but haven't done treatment because the doctor who diagnosed me wanted me to take things like activated charcoal and a thousand supplements - every appointment he changed what medications he would prescribe me). When my gut issues are flaring, as they were this morning, my PEM is worse, including coughing (possibly from acid reflux), sneezing, runny nose and flu like sensations. When my gut settles the symptoms seem to subside. Perhaps it is the reverse of how I've put it there but there seems to be a connection.

 

[Casterofspells]

I have some gut issues (diagnosed with SIBO last year but haven't done treatment because the doctor who diagnosed me wanted me to take things like activated charcoal and a thousand supplements - every appointment he changed what medications he would prescribe me). When my gut issues are flaring, as they were this morning, my PEM is worse, including coughing (possibly from acid reflux), sneezing, runny nose and flu like sensations. When my gut settles the symptoms seem to subside. Perhaps it is the reverse of how I've put it there but there seems to be a connection.

I did have some success with gut biome testing and then targeted probiotics as well as a switch to a high fiber, low carb diet. Didn’t cure me or anything but made my GI issues more bearable for sure.

 

[Covidivici]

I highlighted a few passages:

ELI5 by Zdenek Vrozina on Ex-Twitter:

A new preprint proposes an interesting mechanism for Long COVID - a link between gut dysbiosis - microbial extracellular vesicles - systemic inflammation - neuroinflammation. This is not just correlation. The authors also test functional models.

The main idea - after SARS-CoV-2 infection, patients may develop a persistent alteration of the gut microbiome. This does not only mean a different bacterial composition, but also the production of different signaling particles - so-called gut microbiota-derived extracellular vesicles (GMEVs).

These vesicles are microscopic membrane particles carrying bacterial cargo. Proteins, lipids, nucleic acids, and other immunologically active molecules. The authors propose that they may transmit inflammatory signals from the gut to the rest of the body.

In a cohort of people with Long COVID, the researchers found persistent microbiome alterations up to 12 months after infection. Certain microbial patterns were associated with neurological symptoms such as memory problems, concentration difficulties, or brain fog.

A strong part of the study - the authors did not only analyze patients. They transplanted microbiota from patients with neurological symptoms into germ-free mice. The mice developed impaired intestinal barrier integrity, behavioral changes, and signs of neuroinflammation.

This moves the study beyond typical observational. It does not just say these patients have a different microbiome, but suggests that microbiota associated with Long COVID can transfer pathological effects, at least in experimental models.

The second step is even more interesting. The researchers isolated microbial extracellular vesicles directly from patient stool samples. These vesicles were then tested on intestinal epithelial cells, macrophages, and human iPSC-derived microglia.

The result?

Vesicles from Long COVID samples triggered inflammatory programs, including inflammasome activation and cytokine production (eg IL-1β, TNF), and also activated microglia. In simple words, a microbial product alone produced effects relevant to the neuroimmune axis.

The authors also show that these vesicles can disrupt intestinal barrier integrity. This is important because it could create a feedback loop:

Dysbiosis - more inflammatory vesicles - weaker barrier - more microbial signals entering circulation - more inflammation.

When these vesicles were chronically administered orally to mice, the animals showed microbiome shifts, intestinal inflammation, increased systemic inflammatory markers, and glial activation in the brain. This supports the concept of the gut–immune–brain axis.

This is also interesting in the context of HIV pathogenesis.

In HIV we already know a model where gut damage - microbial translocation - chronic immune activation - blood–brain barrier disruption - neuroinflammation. This study suggests a related principle for Long COVID.

Mechanistic detail. In HIV the key event is early destruction of gut immune cells, particularly CD4 T cells. Here the focus is on microbial extracellular vesicles as mobile carriers of inflammatory signals, which is a relatively new concept.

Another notable factor highlighted in the study is BAFF, a B-cell activating factor. It was increased across several experimental systems and may reflect broader immune dysregulation involving chronic inflammation and B-cell activation!

So this study does not prove that Long COVID has a single cause or that everything can be explained by gut mechanisms. Rather, it suggests that gut-driven neuroinflammation may be a plausible component of the syndrome.

Still, this is one of the more mechanistically interesting studies on Long COVID in recent months. As a strong working hypothesis that dysbiotic microbiota and their vesicles may help sustain chronic inflammation and neurological symptoms after COVID-19.

I've been scratching my head over NHL player Jonathan Toews' recovery from (what appeared to be) Long COVID, following an intense Ayurvedic treatment. I'm not keen on eating butter, induced vomiting, enemas, beatings and severe weight loss. But if this preprint's hypothesis pans out, perhaps a bowel reset really is what did it for him ( ! )

In which case I wonder if FMT (fecal microbiota transplantation) might not be worth investigating. Given that it works (really well) against C.diff. maybe it could help here too?